Jussi Nurmi
University of Turku
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jussi Nurmi.
Clinical Biochemistry | 2003
Minna Kiviniemi; Jussi Nurmi; H. Turpeinen; Timo Lövgren; Jorma Ilonen
OBJECTIVES A reliable high-throughput assay system is necessary for the analysis of the ever-increasing numbers of single-nucleotide polymorphisms (SNP) relevant to genetic screening studies. We describe an assay suitable also for large-scale screening programs. DESIGN AND METHODS The one-step assay is based on asymmetric PCR amplification of the target sequence and subsequent time-resolved fluorescence measurement. Asymmetric amplification results in a single-stranded PCR product that is detected in the amplification vessel with a highly sensitive, homogeneous hybridization method. RESULTS A dual label, homogeneous high-throughput platform for nucleic acid sequence analysis was developed and validated using a C/T single-nucleotide polymorphism in the insulin gene as a model analyte and applied also to two other SNP-assays (poliovirus receptor A/G-polymorphism and CD86-gene exon 2 A/G-polymorphism). CONCLUSIONS The described high-throughput genotyping technology is very competitive in price, simple in design and easily applied to any analyte sequence.
International Journal of Food Microbiology | 2008
Virve Hagren; Piia von Lode; Anniina Syrjälä; Teemu Korpimäki; Mika Tuomola; Otto Kauko; Jussi Nurmi
We describe a system consisting of rapid sample enrichment and homogeneous end-point PCR analysis that enables the detection of Salmonella in various food matrices in 8 h. Sample preparation starts with 6 h enrichment step in supplemented broth, after which Salmonella cells are collected with immunomagnetic particles. The particles are washed and dispensed to ready-to-use PCR reaction vessels, which contain dried assay-specific reagents and an internal amplification control. PCR is performed with a novel instrument platform utilising the sensitive label technology of time-resolved fluorometry. Qualitative assay results are automatically interpreted and available in 45 min after sample addition. The overall accuracy, sensitivity and specificity of the Magda CA Salmonella system were 99.1%, 98.4% and 100.0%, respectively, based on the evaluation of 107 samples (beef, pork, poultry and ready-to-eat meals) artificially contaminated with sub-lethally injured Salmonella cells.
Analytical Biochemistry | 2008
Virve Hagren; Piia von Lode; Anniina Syrjälä; Tero Soukka; Timo Lövgren; Hannu Kojola; Jussi Nurmi
We have developed a novel instrument platform, GenomEra, for small-scale analysis of nucleic acids. The platform combines a rapid thermal cycler, an integrated time-resolved fluorescence measurement unit, and user-friendly software for the analysis of results. Disposable low-cost plastic reaction vessels are designed specifically for the instrument and contain all of the assay-specific reagents in dry form. The appropriate assay protocol is specified on barcodes printed under the vessels and is automatically initiated by the software. Detection is based on the use of sequence-specific probes labeled with intrinsically fluorescent europium or terbium chelates and complementary quencher probes, which enable sensitive, homogeneous closed-tube assays without the risk of carryover contamination. The detection limit of the instrument (background + 3 SD) is approximately 20 pmol/L for both chelates with a dynamic range of nearly four orders of magnitude. The functionality of the platform is demonstrated with a dual-label homogeneous polymerase chain reaction (PCR) assay for the detection of Salmonella using a Magda CA Salmonella assay kit. An internal amplification control is included in each reaction to eliminate false negative results caused by PCR inhibition. Qualitative assay results are automatically interpreted by the software and are available 45 min after sample addition.
Genome Biology | 2005
Seppo Salminen; Jussi Nurmi; Miguel Gueimonde
An intestinal population of beneficial commensal microorganisms helps maintain human health, and some of these bacteria have been found to significantly reduce the risk of gut-associated disease and to alleviate disease symptoms. The genomic characterization of probiotic bacteria and other commensal intestinal bacteria that is now under way will help to deepen our understanding of their beneficial effects.
Analytical Chemistry | 2002
Jussi Nurmi; Tiina Wikman; Matti Karp; Timo Lövgren
Nucleic Acids Research | 2000
Jussi Nurmi; Alice Ylikoski; Tero Soukka; Matti Karp; Timo Lövgren
Diabetes Technology & Therapeutics | 2007
Minna Kiviniemi; Robert Hermann; Jussi Nurmi; Anette-G. Ziegler; Mikael Knip; Olli Simell; Riitta Veijola; Timo Lövgren; Jorma Ilonen
Clinical Biochemistry | 2008
Riina-Minna Väänänen; Maria Rissanen; Otto Kauko; Siina Junnila; Ville Väisänen; Jussi Nurmi; Kalle Alanen; Martti Nurmi; Kim Pettersson
Analytical Biochemistry | 2001
Jussi Nurmi; Minna Kiviniemi; Minna Kujanpää; Minna Sjöroos; Jorma Ilonen; Timo Lövgren
Clinical Chemistry | 2002
Alice Ylikoski; Kim Pettersson; Jussi Nurmi; Kerttu Irjala; Matti Karp; Hans Lilja; Timo Lövgren; Martti Nurmi